Brigit Biofarmaka Teknologi Tbk. vs Prima Multi Usaha Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Prima Multi Usaha Indonesia Tbk. trades at Rp86 (market cap 493B, 3.55M 24h volume). The key difference: Prima Multi Usaha Indonesia Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Prima Multi Usaha Indonesia Tbk. is more actively traded (3.55M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | PMUI | |
|---|---|---|
Market Cap | 172.82B | 493B |
Volume | 592.2K | 3.55M |
Lot | 5.92K | 35.53K |
Turnover | 147.05M | 301.75M |
Average Price | 248.31 | 84.93 |
Value | 147.05M | 301.75M |
Indicative Equilibrium Price | 254 | 86 |
Indicative Equilibrium Volume | 10 | 318 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Prima Multi Usaha Indonesia Tbk (the Company) was established by Notarial Deed No. 32 dated December 6, 2011 by Notary Suhartono Hakim Djajadiputra, S.H.
Read more on PMUI →